Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers and Early Predictors of Prognostic Course, Response to Possible to Possible Treatments and Risk of Over-infection in Patients With COVID-19 Hospitalized in the Critical or Semi-intensive Area.

NCT04873388 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.

NCT NCT04873388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04873388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers and Early Predictors of Prognostic Course, Response to Possible to Possible Treatments and Risk of Over-infection in Patients With COVID-19 Hospitalized in the Critical or Semi-intensive Area.
Lead sponsor
University of Turin, Italy
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2020
Completion date
December 31, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

c-reactive protein, covid19, d-dimer, procalcitonin